Authors: Ron A. Adelman, M.K. George, New Haven, CT, USA


Improvement in visual acuity and macular edema in patients with retinal vein occlusions.


19 patients with retinal vein occlusions were included in the study. Patients received monthly injections of bevacizumab for 3 months. During follw up, additional injection was performed if edema was detected on OCT.

Effectiveness / Safety:

Significant reduction of macular edema was noted. Central macular thickness reduced from a baseline of 455 micron to 274 micron. -0.29 log MAR and -0.35 log MAR improvement in visual acuity were noted after 3rd injection and at the end of follow up respectively.

Take home message:

Intravitreal bevacizumab leads to clinically significant reduction in macular edema as well as improvement in visual acuity.